Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

News | ACC

GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...

March 04, 2023

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

News | ACC

Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions ...

March 03, 2023

Machine learning can be used to help clinicians with early diagnosis

News | FFR Technologies

CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

March 03, 2023

Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, taking place March 4-6, 2023, in New Orleans, LA.

News | Coronavirus (COVID-19)

ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms

March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...

March 03, 2023

Philips Ultrasound Compact System 5500 CV adds to Philips’ cardiology portfolio bringing diagnostic quality cardiac imaging to the patient bedside

News | ACC

Philips Showcases Comprehensive Cardiology Portfolio at ACC23

March 2, 2023 — Royal Philips is showcasing enhancements to its cardiology portfolio at the Annual Scientific Session & ...

March 02, 2023

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: A Look at the Hot Topics from February

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

March 01, 2023

Enterprise-grade digital stethoscope platform brings non-invasive heart disease detection to primary care

News | Artificial Intelligence

Eko Launches SENSORA Cardiac Disease Detection Platform

February 28, 2023 — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and ...

February 28, 2023

The American College of Cardiology Annual Scientific Session & Expo Begins Saturday, Includes Innovative Updates From Smidt Heart Institute Cardiologists, Cardiothoracic Surgeons

News | ACC

ACC Scientific Session 2023 to Feature Smidt Heart Institute Experts

February 28, 2023 — Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart ...

February 28, 2023

Presentations on Additional REDUCE-IT Sub-Population, In-Vitro Data on EPA to Be Featured at the Congress

News | Pharmaceuticals

Amarin Corp. to Present New Data Evaluating Vascept/Vazkepa (Icosapent Ethyl) at ACC23/WCC

February 27, 2023 — Amarin Corporation plc announced that data evaluating the role of VASCEPA /VAZKEPA (icosapent ethyl) ...

February 27, 2023

The DAIC editorial team recently conducted a “One on One” feature interview with Malissa J. Wood, MD, FACC, focusing on women's cardiovascular care, health equity, and her work.

News | Womens Cardiovascular Health

One on One with Malissa J. Wood, MD, FACC: Managing Acute Coronary Syndromes in Women

February 24, 2023 — As the American College of Cardiology (ACC) prepares to commence its 72nd Scientific Session, “ACC23 ...

February 24, 2023

Data show IVC filter use led to few adverse events, even when used prophylactically

News | Interventional Radiology

New study demonstrates inferior vena cava (IVC) filters are safe and effective way to treat venous thromboembolism (VTE)

February 23, 2023 — Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep ...

February 23, 2023

Findings from a global study conducted by the American College of Cardiology (ACC) reveal that more than 1 in 4 cardiologists experience self-reported mental health conditions, or MHCs.

Feature | ACC | Christine Book

ACC Global Survey Finds 1 in 4 Cardiologists Reporting Mental Health Conditions

February 23, 2023 — Findings from a global study conducted by the American College of Cardiology (ACC) reveal that more ...

February 23, 2023

Featured presentation on the time to clinical benefit of sotagliflozin in people with worsening heart failure

News | Heart Failure

New Analyses of Sotagliflozin to be Presented at ACC23

February 23, 2023 — Lexicon Pharmaceuticals, Inc. announced the upcoming presentation of new analyses of results from ...

February 23, 2023

During the American College of Cardiology's 72nd Annual Scientific Session, “ACC Together with WCC,” five keynote presentations will feature premier experts covering issues facing all who deliver cardiovascular health care today. ACC.23/WCC will take place March 4-6 in New Orleans, LA.

News | ACC

Keynote Speakers to Address Timely Issues at ACC.23

February 22, 2023 — A range of hot topics will be the focus of five ACC23.WCC keynote presentations to be delivered ...

February 22, 2023

NEXLETOL (bempedoic acid) is the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint –

News | Cardiovascular Clinical Studies

Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC

February 20, 2023 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

February 20, 2023